Conzen SD - Search Results

1

Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth.

Kach J, Long TM, Selman P, Tonsing-Carter EY, Bacalao MA, Lastra RR, de Wet L, Comiskey S, Gillard M, VanOpstall C, West DC, Chan WC, Griend DV, Conzen SD, Szmulewitz RZ. Kach J, et al. Among authors: conzen sd. Mol Cancer Ther. 2017 Aug;16(8):1680-1692. doi: 10.1158/1535-7163.MCT-16-0923. Epub 2017 Apr 20. Mol Cancer Ther. 2017. PMID: 28428441 Free PMC article.

2

The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells.

Moran TJ, Gray S, Mikosz CA, Conzen SD. Moran TJ, et al. Among authors: conzen sd. Cancer Res. 2000 Feb 15;60(4):867-72. Cancer Res. 2000. PMID: 10706096

3

Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells.

Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD. Wu W, et al. Among authors: conzen sd. Cancer Res. 2004 Mar 1;64(5):1757-64. doi: 10.1158/0008-5472.can-03-2546. Cancer Res. 2004. PMID: 14996737

4

Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells.

Wu W, Zou M, Brickley DR, Pew T, Conzen SD. Wu W, et al. Among authors: conzen sd. Mol Endocrinol. 2006 Oct;20(10):2304-14. doi: 10.1210/me.2006-0131. Epub 2006 May 11. Mol Endocrinol. 2006. PMID: 16690749

5

Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.

Szmulewitz RZ, Chung E, Al-Ahmadie H, Daniel S, Kocherginsky M, Razmaria A, Zagaja GP, Brendler CB, Stadler WM, Conzen SD. Szmulewitz RZ, et al. Among authors: conzen sd. Prostate. 2012 Feb 1;72(2):157-64. doi: 10.1002/pros.21416. Epub 2011 May 11. Prostate. 2012. PMID: 21563193 Free PMC article.

6

Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer.

Pan D, Kocherginsky M, Conzen SD. Pan D, et al. Among authors: conzen sd. Cancer Res. 2011 Oct 15;71(20):6360-70. doi: 10.1158/0008-5472.CAN-11-0362. Epub 2011 Aug 25. Cancer Res. 2011. PMID: 21868756 Free PMC article.

7

Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.

Skor MN, Wonder EL, Kocherginsky M, Goyal A, Hall BA, Cai Y, Conzen SD. Skor MN, et al. Among authors: conzen sd. Clin Cancer Res. 2013 Nov 15;19(22):6163-72. doi: 10.1158/1078-0432.CCR-12-3826. Epub 2013 Sep 9. Clin Cancer Res. 2013. PMID: 24016618 Free PMC article.

8

Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.

Isikbay M, Otto K, Kregel S, Kach J, Cai Y, Vander Griend DJ, Conzen SD, Szmulewitz RZ. Isikbay M, et al. Among authors: conzen sd. Horm Cancer. 2014 Apr;5(2):72-89. doi: 10.1007/s12672-014-0173-2. Epub 2014 Mar 11. Horm Cancer. 2014. PMID: 24615402 Free PMC article.

9

Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma.

Stringer-Reasor EM, Baker GM, Skor MN, Kocherginsky M, Lengyel E, Fleming GF, Conzen SD. Stringer-Reasor EM, et al. Among authors: conzen sd. Gynecol Oncol. 2015 Sep;138(3):656-62. doi: 10.1016/j.ygyno.2015.06.033. Epub 2015 Jun 24. Gynecol Oncol. 2015. PMID: 26115975 Free PMC article.

10

Targeting the glucocorticoid receptor in breast and prostate cancers.

Kach J, Conzen SD, Szmulewitz RZ. Kach J, et al. Among authors: conzen sd. Sci Transl Med. 2015 Sep 16;7(305):305ps19. doi: 10.1126/scitranslmed.aac7531. Sci Transl Med. 2015. PMID: 26378243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page